+9.28% for Injective as momentum slows near upper end of $3.59

Traders Union
All News
Crypto
Injective jumps 9.28% higher today

Highlights

INJ maintains a bullish short- and medium-term structure after a breakout above key moving averages, though it remains capped by longer-term resistance.
Momentum signals are strong with persistent buyer control, but overbought technical indicators suggest limited immediate upside potential.
INJ is expected to fluctuate between $3.59 and $3.77 over the next five sessions, with downside risk favored unless $3.80 is decisively surpassed.

Bullish structure as short-term momentum faces overbought risk

The INJ price has moved decisively above the MA-20 at $3.35 and MA-50 at $3.12, confirming a bullish short- and medium-term structure, while still trading well below the long-term MA-200 at $4.70, which maintains longer-term pressure from above. The D1 Ichimoku Kijun sits at $3.49, placing it below the current price and marking it as immediate support. Momentum indicators are firmly positive: both D1 MACD and ADX signal persistent buyer control; the RSI is elevated at 62.7. However, Stoch RSI and CCI both point to overbought conditions. BBP readings highlight continued buyer dominance, while the Awesome Oscillator is neutral and a slight momentum divergence suggests potential exhaustion on shorter timeframes.

Sideways bias as downside risks outweigh bullish impulses

For the next five trading days, INJ is expected to consolidate between $3.59 and $3.77, reflecting a typical volatility band relative to current levels. The probability of further price increases is low (less than 20%), with current signals indicating a higher risk of decline given the bearish alignment of major weekly indicators. The baseline scenario envisions a sideways corridor above $3.60. A bullish outcome would require an impulsive break above $3.80, while a bearish scenario could unfold if price slips below $3.60, at which point downside risk would increase.

Anton Kharitonov, expert at Traders Union, notes that INJ’s technical structure remains bullish in the short term, but longer-term resistance still looms. He sees momentum indicators in buyer territory, though overbought signals and the absence of fresh news temper confidence. The analyst remains cautious given the risk of pullback if $3.60 fails. "Until price decisively clears $3.80, I see consolidation as the most likely scenario for INJ."

Earlier, analysts noted that Injective was exhibiting short-term momentum while longer-term resistance and overbought signals suggested caution for traders. The latest technical setup underscores that, despite strong near-term buying pressure, downside risk remains elevated if the price breaks below $3.60 in the coming sessions.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.